|
⚲
|
| Keyboard |
| Smith Brendan
✚
|
|
|---|---|
| CIK # | 0001857492 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001857492] | |
| 4 | [0001857492] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| CRISPR Therapeutics AG | |
| Smith Brendan | |
| Translate Bio Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2023-02-21 | Tax withheld | 1,392 | $48.26 | 67,178 |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2023-02-18 | Option exercise | 3,825 | ||
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2023-02-18 | Option exercise | 3,825 | ||
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2022-10-17 | Tax withheld | 1,111 | $55.76 | 61,949 |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2022-10-14 | Option exercise | 3,750 | ||
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2022-10-14 | Option exercise | 3,750 | ||
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2022-10-07 | Grant | 14,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2022-08-16 | Grant | 10,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2022-02-18 | Grant | 30,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2022-02-18 | Grant | 15,300 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2021-10-14 | Grant | 90,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2021-10-14 | Grant | 15,000 | $0.00 | |
|
Translate Bio Inc TBIO
Stcok Option (right to buy) · derivative
|
2021-09-14 | Sell | 201,800 | $0.00 | |
|
Translate Bio Inc TBIO
Stock Option (Right to Buy) · derivative
|
2021-04-19 | Grant | 201,800 | $0.00 |